CNBX PHARMACEUTICALS INC.
Profit Margins
| Period | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| Feb 2016 | 100.0% | -1,098.4% | -1,175.4% |
| May 2016 | 100.0% | -27.7% | -53.0% |
| Feb 2017 | 100.0% | -15,490.3% | -35,261.5% |
| May 2017 | 100.0% | -30,100.3% | -15,622.4% |
| Aug 2017 | 100.0% | -37,825.9% | -38,435.5% |
| Nov 2017 | 100.0% | -30,543.3% | -30,574.7% |
| Feb 2018 | 100.0% | -88,112.2% | -84,674.7% |
| May 2018 | — | -28,814.5% | -29,491.7% |
| Aug 2018 | — | -24,309.0% | -24,772.4% |
| Nov 2018 | 100.0% | -19,615.4% | -19,848.0% |
| Feb 2019 | — | -38,622.7% | 160,761.5% |
| May 2019 | — | -36,089.0% | -25,344.9% |
| Aug 2019 | — | -47,606.8% | -67,700.3% |
| Nov 2019 | — | -46,514.0% | -293,169.6% |
| Feb 2020 | — | -66,135.0% | -66,249.2% |
| May 2020 | — | -36,612.6% | -38,476.9% |
| Aug 2020 | — | -30,390.3% | -33,154.9% |
| May 2023 | — | -55.8% | -49.9% |
| Aug 2023 | — | -161.5% | -573.6% |
| Nov 2023 | — | -192.2% | -199.6% |
| Feb 2024 | 84.7% | -508.0% | -800.9% |